<PAGE>
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
SCHEDULE 13G
(RULE 13d-102)
INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT
TO RULES 13d-1(b) AND (c) AND AMENDMENTS THERETO FILED
PURSUANT TO 13d-2(b)
(AMENDMENT NO. 3)/1/
Cambridge Heart, Inc.
---------------------
(Name of Issuer)
Common Stock, par value $.001 per share
---------------------------------------
(Title of Class of Securities)
131910101
---------
(CUSIP Number)
/1/The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
<PAGE>
CUSIP NO. 131910101 Page 2 of 6
===============================================================================
SCHEDULE 13G
- ------------------------------------------------------------------------------
NAMES OF REPORTING PERSONS.
1 I.R.S. IDENTIFICATION NOS. OF ABOVE PERSONS (ENTITIES ONLY).
Dr. Richard J. Cohen
- ------------------------------------------------------------------------------
CHECK THE APPROPRIATE BOX IF A MEMBER OF A GROUP (SEE INSTRUCTIONS)
2 (a) [_]
(b) [_]
- ------------------------------------------------------------------------------
SEC USE ONLY
3
- ------------------------------------------------------------------------------
CITIZENSHIP OR PLACE OF ORGANIZATION
4 United States of America
- ------------------------------------------------------------------------------
SOLE VOTING POWER
5 1,282,385 shares (Includes 8,000 shares issuable
NUMBER OF within 60 days of December 31, 1999 upon the issuance
of vested stock options.)
SHARES -----------------------------------------------------------
SHARED VOTING POWER
BENEFICIALLY 6 0 shares.
OWNED BY
-----------------------------------------------------------
EACH SOLE DISPOSITIVE POWER
7 1,282,385 shares (Includes 8,000 shares issuable
REPORTING within 60 days of December 31, 1999 upon the issuance
of vested stock options.)
PERSON -----------------------------------------------------------
SHARED DISPOSITIVE POWER
WITH 8 0 shares.
- ------------------------------------------------------------------------------
AGGREGATE AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
9 1,282,385 shares (Includes 8,000 shares issuable within 60 days of
December 31, 1999 upon the issuance of vested stock options.)
- ------------------------------------------------------------------------------
CHECK BOX IF THE AGGREGATE AMOUNT IN ROW (9) EXCLUDES CERTAIN SHARES
10 Not Applicable
- ------------------------------------------------------------------------------
PERCENT OF CLASS REPRESENTED BY AMOUNT IN ROW (9)
11 8.8%
- ------------------------------------------------------------------------------
TYPE OF REPORTING PERSON*
12 IN
- ------------------------------------------------------------------------------
*SEE INSTRUCTION BEFORE FILLING OUT!
<PAGE>
CUSIP NO. 131910101 Page 3 of 6
Item 1(a) Name of Issuer:
- --------- --------------
Cambridge Heart, Inc.
Item 1(b) Address of Issuer's Principal Executive Office:
- --------- ----------------------------------------------
One Oak Park Drive
Bedford, Massachusetts 01730
Item 2(a) Name of Person Filing:
- --------- ---------------------
Dr. Richard J. Cohen
Item 2(b) Address of Principal Business Office or, if none, Residence:
- --------- -----------------------------------------------------------
c/o Massachusetts Institute of Technology
45 Carlton Street
Room E25-335A
Cambridge, MA 02139
Item 2(c) Citizenship:
- --------- -----------
United States of America.
Item 2(d) Title of Class of Securities:
- --------- ----------------------------
Common Stock, $.001 par value per share.
Item 2(e) CUSIP Number:
- --------- ------------
131910101
Item 3 Description of Person Filing:
- ------ ----------------------------
Not applicable.
<PAGE>
CUSIP NO. 131910101 Page 4 of 6
Item 4 Ownership:
- ------ ---------
(a) Amount Beneficially Owned:
-------------------------
1,282,385 shares (Includes 8,000 shares issuable within 60 days
of December 31, 1999 upon the exercise of vested stock options.)
(b) Percent of Class:
----------------
8.8%
(c) Number of shares as to which person has:
---------------------------------------
(i) sole power to vote or to direct the vote:
1,282,385 shares (Includes 8,000 shares issuable within
60 days of December 31, 1999 upon the exercise of
vested stock options.)
(ii) shared power to vote or to direct the vote:
0 shares
(iii) sole power to dispose or to direct the
disposition of:
1,282,385 shares (Includes 8,000 shares issuable within
60 days of December 31, 1999 upon the exercise of
vested stock options.)
(iv) shared power to dispose or to direct the
disposition of:
0 shares
Item 5 Ownership of Five Percent or Less of a Class:
- ------ --------------------------------------------
Not applicable.
Item 6 Ownership of More than Five Percent on Behalf of Another Person:
- ------ ---------------------------------------------------------------
Not applicable.
Item 7 Identification and Classification of the Subsidiary Which Acquired the
- ------ ----------------------------------------------------------------------
Security Being Reported on by the Parent Holding Company:
--------------------------------------------------------
Not applicable.
<PAGE>
CUSIP NO. 131910101 Page 5 of 6
Item 8 Identification and Classification of Members of the Group:
- ------ ---------------------------------------------------------
Not applicable.
Item 9 Notice of Dissolution of Group:
- ------ ------------------------------
Not applicable.
Item 10 Certification:
- ------- -------------
Not applicable.
<PAGE>
CUSIP NO. 131910101 Page 6 of 6
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify
that the information set forth in this statement is true, complete and correct.
DATED: February 14, 2000
/s/ Richard J. Cohen
-------------------------------
Richard J. Cohen, M.D., Ph.D.
